The Latest Policy News Affecting Scientists
In response to the recent actions taken by the federal government affecting scientists and their research, ASPET leadership released the following statements to its members on January 29th and February 11th, respectively.
Statement on Executive Orders
The American Society for Pharmacology and Experimental Therapeutics (ASPET) leadership and staff are closely monitoring the various Executive Orders and directives that impact the work of our pharmacology community. In particular, we are monitoring the constantly evolving status of the communication freeze at NIH and the temporary pause on federal grants announced by the White House.
We understand that these are very extraordinary times for the pharmacology community. ASPET will continue to monitor these developments and update you as we gather more details on how these changes will impact your work.
The ASPET Science Policy Committee and ASPET staff are dedicated to monitoring and responding to government actions impacting the pharmacology community. If you have any questions, or would like to know how to become more involved, do not hesitate to reach out to the Department of Government Affairs and Science Policy at publicaffairs@aspet.org.
Statement on NIH Funding Cuts
In the wake of the February 7, 2025 NIH supplemental guidance that set a cap on the indirect cost rate for federal grants, ASPET launched its advocacy campaign calling on Congress to stop the cuts to indirect costs. You can participate here.
ASPET recognizes that these are unusual times and some of its members may have been told by university officials not to speak out on how the cuts could affect their universities. ASPET created an anonymous way for you to share how the cuts are going to impact you and the locality. You can participate here.
Also, in light of the continued “freeze” on funding, ASPET launched the ability for you to share the impact of the freeze on your science. Any information provided will assist ASPET in its advocacy efforts.
As these situations unfold, ASPET will continue to provide updates to members and provide ways for the ASPET community to advocate for pharmacology.